SCHEMBL7413629

SCHEMBL7413629

CC(C)(C)OC(=O)NC(C(=O)N1CCCC1)c1ccc(Cl)c([N+](=O)[O-])c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.43
NPY1R P25929 1/20 0.41
MC4R P32245 1/20 0.41
NPY2R P49146 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
BCL2 P10415 4/20 0.40
MCL1 Q07820 2/20 0.40
VCAM1 P19320 1/20 0.39
NPBWR1 P48145 1/20 0.38
MCHR1 Q99705 1/20 0.38
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
MAPT P10636 3/20 0.38
POLB P06746 1/20 0.38
S1PR3 Q99500 1/20 0.38
ALDH1A1 P00352 3/20 0.37
LMNA P02545 2/20 0.37
RECQL P46063 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7421439 0.87 HCAR3 (0.40) NPC1MEN1KMT2AMAPTALDH1A1
SCHEMBL22617062 0.81 MEN1 (0.46) MC4RMEN1KMT2AS1PR3ALDH1A1
SCHEMBL7411897 0.78 MAPK1 (0.44) NPY1RMC4RNPY2RL3MBTL1BCL2
SCHEMBL16379880 0.77 CTSK (0.43) MEN1KMT2APOLB
SCHEMBL21468963 0.77 CTSK (0.43) MEN1KMT2APOLB
SCHEMBL20434046 0.76 CTSS (0.55) L3MBTL1KMT2AMAPK1
SCHEMBL5443088 0.75 CTSS (0.54) KMT2A
SCHEMBL5445090 0.75 CTSS (0.54) KMT2A
SCHEMBL7411883 0.74 AAK1 (0.41)
SCHEMBL11262003 0.72 GRM4 (0.41) L3MBTL1BCL2MCL1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1095025-B1 BENZIMIDAZOLES, PRODUCTION THEREOF AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA (DE) 2002-12-11 EP disclosed
US-6248770-B1 CARDIOVASCULAR DISORDERS BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-06-19 US disclosed